BACKGROUND: Iron deficiency has been reported to be highly prevalent in idiopathic pulmonary arterial hypertension (iPAH) patients, with the potential to influence cardiac performance, pulmonary artery pressures and the pulmonary vascular response to hypoxia.METHODS: Iron status was evaluated in 29 iPAH patients, and was related to haemodynamic, echocardiographic and exercise parameters.RESULTS: Iron deficiency was present in 44.8% of all iPAH patients, although anaemia was only present in 13.8%. Iron-deficient patients had similar exercise capacity (6MWD: 446±141 m), compared to iron-sufficient patients (421±193 m), however 46.2% of iron deficient patients had NYHA FC 3 or higher, compared to 12.5% in non-iron deficient group. Additionally...
Introduction: Iron is a critical ion in the regulation of many cellular processes and iron deficien...
Background Iron bioavailability has been identified as a factor influencing cellular hypoxia sensing...
Background Pulmonary arterial hypertension (PAH) is a progressive disease with limited survival. Iro...
BACKGROUND: Iron deficiency has been reported to be highly prevalent in idiopathic pulmonary arteria...
ABSTRACT: Iron deficiency is known to be common and detrimental in chronic left heart failure, where...
Iron deficiency is prevalent in idiopathic pulmonary arterial hypertension (IPAH), but whether iron ...
<div><p>Purpose</p><p>Iron deficiency is prevalent in idiopathic pulmonary arterial hypertension (IP...
Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease that is caused by the progr...
ObjectivesThis study sought to understand the prevalence and clinical relevance of iron deficiency i...
International audienceIn left heart failure, iron supplementation (IS) is a first-line treatment opt...
Imbalances of iron homeostasis are associated with an adverse clinical outcome of pulmonary hyperten...
The purpose of this review article is to provide a comprehensive review of iron deficiency in the se...
Imbalances of iron homeostasis are associated with an adverse clinical outcome of pulmonary hyperten...
Iron deficiency affects up to one-third of the world's population, and is particularly common in eld...
Background: Iron deficiency affects up to 50% of patients with pulmonary arterial hypertension (PAH)...
Introduction: Iron is a critical ion in the regulation of many cellular processes and iron deficien...
Background Iron bioavailability has been identified as a factor influencing cellular hypoxia sensing...
Background Pulmonary arterial hypertension (PAH) is a progressive disease with limited survival. Iro...
BACKGROUND: Iron deficiency has been reported to be highly prevalent in idiopathic pulmonary arteria...
ABSTRACT: Iron deficiency is known to be common and detrimental in chronic left heart failure, where...
Iron deficiency is prevalent in idiopathic pulmonary arterial hypertension (IPAH), but whether iron ...
<div><p>Purpose</p><p>Iron deficiency is prevalent in idiopathic pulmonary arterial hypertension (IP...
Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease that is caused by the progr...
ObjectivesThis study sought to understand the prevalence and clinical relevance of iron deficiency i...
International audienceIn left heart failure, iron supplementation (IS) is a first-line treatment opt...
Imbalances of iron homeostasis are associated with an adverse clinical outcome of pulmonary hyperten...
The purpose of this review article is to provide a comprehensive review of iron deficiency in the se...
Imbalances of iron homeostasis are associated with an adverse clinical outcome of pulmonary hyperten...
Iron deficiency affects up to one-third of the world's population, and is particularly common in eld...
Background: Iron deficiency affects up to 50% of patients with pulmonary arterial hypertension (PAH)...
Introduction: Iron is a critical ion in the regulation of many cellular processes and iron deficien...
Background Iron bioavailability has been identified as a factor influencing cellular hypoxia sensing...
Background Pulmonary arterial hypertension (PAH) is a progressive disease with limited survival. Iro...